Quotient Sciences highlights the value of true integration across drug development, combining formulation development, GMP manufacturing, and clinical testing within a single organization.
In Drug Development & Delivery, Quotient Sciences’ Dr. Vanessa Zann, Vice President, Scientific Consulting, Translational Pharmaceutics & Clinical Pharmacology USA, underscores the importance of integration in outsourcing.
Dr. Zann highlights the company’s Translational Pharmaceutics® platform, which brings formulation development, GMP manufacturing, and clinical testing together within a single program that streamlines decision-making and eliminates inefficiencies of working with separate CRO and CDMO partners.
Translational Pharmaceutics® supports more efficient progression from early development to clinical studies, improving speed to clinic while maintaining quality, scientific rigor, and regulatory alignment. Continue reading: SPECIAL FEATURE - Outsourcing Formulation Development & Manufacturing: Connecting Your Project to the Right Service Provider.